RESUMO
BACKGROUND: We previously demonstrated a possible therapeutic benefit of VFEM (variable frequency electromagnetic energy) technology for the treatment of Post Treatment Lyme Disease Syndrome (PTLDS) or Chronic Lyme Disease (CLD). As a result, we prospectively enrolled 10 patients, all having significant debility, to determine to what extent we could improve their quality of life. Eight patients completed the 10 treatments. RESULTS: All eight patients had a significant improvement in quality of life within a 4-month time frame. CONCLUSION: VFEM is a stand-alone modality that appears to demonstrate a significant improvement in quality of life in PTLDS or CLD with little or no risk or side effects of treatment.
Assuntos
Síndrome Pós-Lyme , Qualidade de Vida , Humanos , Estudos Prospectivos , Feminino , Pessoa de Meia-Idade , Masculino , Adulto , Síndrome Pós-Lyme/terapia , Síndrome Pós-Lyme/diagnóstico , Doença de Lyme/complicações , Doença de Lyme/tratamento farmacológico , Doença de Lyme/diagnóstico , Doença de Lyme/terapia , Resultado do Tratamento , Magnetoterapia/métodos , Magnetoterapia/instrumentação , IdosoRESUMO
Lyme disease is an infection caused by Borrelia burgdorferi sensu lato, which is transmitted to humans through the bite of an infected Ixodes tick. The majority of patients recover without complications with antibiotic therapy. However, for a minority of patients, accompanying non-specific symptoms can persist for months following completion of therapy. The constellation of symptoms such as fatigue, cognitive dysfunction, and musculoskeletal pain that persist beyond 6 months and are associated with disability have been termed post-treatment Lyme disease syndrome (PTLDS), a subset of a broader term "chronic Lyme disease." Chronic Lyme disease is a broad, vaguely defined term that is used to describe patients with non-specific symptoms that are attributed to a presumed persistent Borrelia burgdorferi infection in patients who may or may not have evidence of either previous or current Lyme disease. The diagnoses of chronic Lyme disease and of PTLDS have become increasingly relevant to the practice of immunologists due to referrals for consultation or for intravenous immunoglobulin (IVIG) treatment. This review aims to explore the relationship between chronic Lyme disease, post-treatment Lyme disease syndrome, and the immune system. Here, we review the current literature on (1) issues in conventional and alternative diagnostic testing for Lyme disease, (2) the hypothesis that B. burgdorferi infection can persist despite appropriate use of recommended antibiotics, (3) current theories regarding B. burgdorferi's role in causing both immune dysregulation and protracted symptoms, and (4) the use of IVIG for the treatment of Lyme disease.
Assuntos
Borrelia burgdorferi , Ixodes , Doença de Lyme , Síndrome Pós-Lyme , Animais , Fadiga/etiologia , Humanos , Doença de Lyme/complicações , Doença de Lyme/diagnóstico , Doença de Lyme/terapia , Síndrome Pós-Lyme/complicações , Síndrome Pós-Lyme/diagnóstico , Síndrome Pós-Lyme/terapiaRESUMO
There's an on-going discussion about chronic Lyme Disease: are the persisting symptoms some patients experience due to an inadequately treated Borrelia infection or is something else going on? In 2017 the National Lyme Disease Centre (NLe) has been established in the Netherlands. Two university medical centres, the RIVM and the Lyme Organization participate in the NLe where diagnostics and treatment are offered to patients and research into Lyme disease is carried out. Ideally, collaboration between doctors, researchers and patients leads to research that addresses relevant and urgent questions. Regarding chronic Lyme disease not as a hype but a hypothesis that needs to be verified or falsified, could help both doctors and patients, assuming that they can conclude together that some notions might have seemed rational, but nonetheless have to be discarded based on the results of sound scientific research. That might open new ways to explore treatment of persisting symptoms.
Assuntos
Síndrome Pós-Lyme/diagnóstico , Síndrome Pós-Lyme/terapia , Borrelia burgdorferi/isolamento & purificação , Doença Crônica , Humanos , Doença de Lyme/diagnóstico , Doença de Lyme/terapia , Masculino , Países BaixosRESUMO
Lyme borreliosis is the most common tick-borne infectious disease in Europe. A neurological manifestation occurs in 3-15% of infections and can manifest as polyradiculitis, meningitis and (rarely) encephalomyelitis. This S3 guideline is directed at physicians in private practices and clinics who treat Lyme neuroborreliosis in children and adults. Twenty AWMF member societies, the Robert Koch Institute, the German Borreliosis Society and three patient organisations participated in its development. A systematic review and assessment of the literature was conducted by the German Cochrane Centre, Freiburg (Cochrane Germany). The main objectives of this guideline are to define the disease and to give recommendations for the confirmation of a clinically suspected diagnosis by laboratory testing, antibiotic therapy, differential diagnostic testing and prevention.